1. Home
  2. KVYO vs AMRX Comparison

KVYO vs AMRX Comparison

Compare KVYO & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$16.82

Market Cap

4.3B

Sector

N/A

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$16.96

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
AMRX
Founded
2012
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.0B
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
KVYO
AMRX
Price
$16.82
$16.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
5
Target Price
$34.48
$15.60
AVG Volume (30 Days)
4.8M
2.2M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
157.89
EPS
0.03
0.19
Revenue
$1,234,019,000.00
N/A
Revenue This Year
$24.47
$4.48
Revenue Next Year
$19.66
$7.13
P/E Ratio
$572.00
$89.53
Revenue Growth
31.63
N/A
52 Week Low
$12.53
$7.67
52 Week High
$36.76
$17.86

Technical Indicators

Market Signals
Indicator
KVYO
AMRX
Relative Strength Index (RSI) 59.65 68.98
Support Level $15.85 $12.46
Resistance Level $21.74 $17.86
Average True Range (ATR) 0.85 0.54
MACD 0.36 -0.13
Stochastic Oscillator 81.74 54.92

Price Performance

Historical Comparison
KVYO
AMRX

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: